Smith & Nephew PLC
SN.
ISIN GB0009223206 / Valor 1103058
Smith & Nephew PLC
UMushroom community rating:
About company
Smith & Nephew PLC is a global medical technology company specializing in products and solutions for the repair, regeneration, and replacement of soft and hard tissues. The company operates across several key areas, including Sports Medicine, Ear, Nose & Throat (ENT), and Advanced Wound Management, providing instruments and devices that address diverse clinical needs. Through strategic acquisitions such as Herts Pharmaceuticals, Osiris Therapeutics, Ceterix Orthopaedics, Leaf Patient Monitoring System, and Brainlab's Orthopaedic Joint Reconstruction Business, Smith & Nephew has expanded its portfolio to include pharmaceutical and skincare products, as well as advanced patient monitoring technologies. These expansions enable the company to enhance its research and development capabilities, fostering innovation to meet the evolving demands of the global healthcare market.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
12679 M
Market cap (USD)
3,714,747
Daily traded volume (Shares)
9.85 / 9.77
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
